11 05 2014 Lipid drugs Flashcards

1
Q

What are the types of drugs used to treat hyperlipidemias?

A
  1. HMG-CoA reductase Inhibitors ( AKA STATINS)
  2. Bile-absorbing Resins
  3. Niacin
  4. Fibrates
  5. Cholesterol absorbing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who are the Statins used?

A
Lovastatin
Atorvastatin
Fluvastatin
Pravastatin
Simvastatin
Rosuvastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanism of statins and their benefits due to the mechanism?

A

inhibit HMG CoA reductase = blocks denovo cholesterol synthesis
= deplete the intracellular supply of cholesterol. Now patient needs to use cholesterol in blood.

  1. increase LDL receptor
  2. Remove LDL from blood
  3. Decrease hepatic VLDL production

Benefits:
- Decrease in LDL = plaque stabilization
- Plaque stabilization = decrease in thrombotic event
- Also decreases the vulnerability of LDL oxidation
= anti-inflammatory effect
- improvement of coronary endothelial function due to increase synthesis of NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Overall effect of Statin use? And who benefit most from it?

A

Lowering of LDL and increase HDL

EVERYONE – any familial hyperlipidemia and CAD patients (improve mortality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacokinetics of statins?

A
  • All delivered orally
    - absorption enhanced by food
  • All have high first pass extraction
  • All are bio-transformed into products that retain activity
  • excreted via bile and feces but some are eliminated via kidneys

Lovastin and Simvastatine are Pro drugs (30-50% available)

Rosuvastatin and atorvastatin are most potent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adverse effects of statins?

A
  1. Dose related HEPATOTOXICITY
    * check AST and ATL enzymes
  2. Myopathy of proximal legs and arms symmetrically (especially with combination w/ niacin and vibrates)
    * check creatine levels regularly
    - Rhabdomyolysis: myoglobinuria ** renal failure
  3. Drug interaction !! * CYP34A – P450
  4. Contraindicated in pregnancy and nursing mothers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the names of the bile acid sequestrates (resins) used?

A

Cholestyramine
Colestipol
Colesevelam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the overall result of bile acid sequestrate use?

A

Decrease LDLs (not as well as statins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of Bile acid resins?

A

(+) charged resin that binds to (-) charged bile acid/salt in the small intestine
-complex is excreted in feces

PREVENTS bile salts from returning to liver via enterohepatic circulation

Decrease bile = decrease LDL in plasma = bile acid synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the therapeutic uses for Resins?

A

Heterozygous Familial hyperlipidemias ( type IIa: increase in LDL with no increase in VLDL); and Type IIb: increase in LDL and VLDL)

Patients with cholestasis/ bile salt accumulation

Removal of digitalis from GI tract

Must take with food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacokinetics of resins?

A
  • Oral
  • Not absorbed or metabolized because they are insoluble in water AND they are HUGE!!
  • totally excreted in feces
  • potency is less than statins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adverse effects of resins?

A
  1. GI: constipation, flatulence, nausea
    - Colesevelam has less GI effects
  2. Impaired absorption of fat soluble vitamins A, D, E, and K
  3. Drug interactions: Cholestyramine and Colestipol interfere with MANY DRUGS
  4. Cause increase in cholesterol synthesis = increase in VLDL = increase in TAG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Niacin

  1. Overall effect
A

Decrease in LDL AND TAGS
* great for treatment of familial hyperlipidemias

Most effective agent for increase in HDL

Also known to decrease lipoprotein(a)
-cardivascular disease risk factor when elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of niacin

A

inhibits lipolysis of adipose tissue
= decrease in FFA
- have to use VLDL = decrease in LDL

Increase in HDL by blocking Apo AI reuptake

Reverse endothelial cell dysfunction and thrombosis due to an increase in plasminogen activator and decrease level of plasma fibrinogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adverse Effects of niacin

A
  1. intense cutaneous flush due to increase in prostacyclin (take aspirin)
  2. Nausea and exacerbation of peptic ulcers
  3. Gout/ Hyperuricemia
  4. impaired glucose tolerance
  5. Hepatotoxicity: fatigue, weakness, increase in AST and ALTs
  6. Myopathy when prescribed with statins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Overall therapeutic effect of Fibrates? What are the names of Fibrates?

A

decrease TAGs and increase HDL

  • Fenofibrate
  • Gemfibrazil

Type III, IV< and V familial hyperlipidemia

17
Q

mechanism of action for fibrates?

A

Block PPAR alpha : peroxisomer proliferator-activated receptor : regulators of lipid metabolism
-ligand activated transcription factors

Blockage = increase expression of lipoprotein lipase and decrease ApoCII concentration
= increase HDL via increasing api AI and apo AII expression

18
Q

Pharmacokinetics of Fenofibrate

A

Prodrug! and is more effective than gemfibroazil

19
Q

Pharacokinetics of Fibrates in general:

A
  1. oral
  2. distribute widely
  3. bound to albumin
  4. undergo extensive biotransformation and are excreted in urine
20
Q

Adverse effects of Fibrates

A
  1. GI
  2. Lithiasis = increase cholesterol excretion = gallstone formation
  3. myositis: inflammation of voluntary muscles
  4. Drug interactions: compete with coumarin anti coagulates = potentiate their effect
  5. DO NOT USE during Pregnancy or breast feeding
  6. raise lipoprotein lipase = increase VLDL catabolism = raise circulating LDL — bad in patients with baseline hyperlipidemia
21
Q

Overall effect of Ezetimibe

A

Cholesterol absorption inhibitor

Decrease LDL and TAGs

No adverse effects

22
Q

Mechanism of Ezetimibe

A

selective inhibitor of cholesterol uptake at the brush border of epithelial cells in the small intestine

23
Q

Pharmacokinetics of Ezetimibe

A

metabolized in small intestine and liver via phase II : glucuronide conjugation

Excreted viliary and renal

T1/2 = 22 hrs